4D Molecular Therapeutics Inc (FDMT)
EBITDA Growth
-41.69%
Quarterly · Period ending:
FDMT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-41.69%period ending
Latest reported-41.69%period ending
FDMT Quarterly EBITDA YoY % (-241.21% → -41.69%)
Year-over-year change
High-resolution chart · PNG
FDMT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -41.6904% | |
| -44.3269% | |
| 125.8651% | |
| -30.2159% | |
| -58.3306% | |
| -50.0243% | |
| -55.6289% | |
| -375.6208% | |
| -18.2383% | |
| -12.9703% | |
| -18.3871% | |
| 64.2915% | |
| -3.4232% | |
| -6.7068% | |
| -13.5772% | |
| -15.5175% | |
| -298.0575% | |
| -60.4168% | |
| -14.129% | |
| -188.4249% | |
| 53.7052% | |
| -23.181% | |
| -25.5542% | |
| 35.8349% | |
| -73.5203% | |
| -51.7334% | |
| -578.708% | |
| -393.2427% | |
| -241.213% | |
| -241.213% |